Tacrolimus: Difference between revisions
(creating tacrollimus) |
(tacrolimus) |
||
| Line 1: | Line 1: | ||
==Administration== | ==Administration== | ||
*Type: | *Type: immunosuppressant | ||
*Dosage Forms: | *Dosage Forms: 0.5,1,5 | ||
*Routes of Administration: | *Routes of Administration: PO, topical, IV | ||
*Common Trade Names: | *Common Trade Names:Prograf | ||
==Adult Dosing== | ==Adult Dosing== | ||
Revision as of 03:10, 9 February 2016
Administration
- Type: immunosuppressant
- Dosage Forms: 0.5,1,5
- Routes of Administration: PO, topical, IV
- Common Trade Names:Prograf
Adult Dosing
Pediatric Dosing
Special Populations
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: